Abstract
Most experimental tumors induced with chemical carcinogens or UV radiation express individually specific transplantation antigens that elicit a T cell-mediated immune rejection in the syngeneic animals (Prehn and Main 1957; Klein et al. 1960; Kripke 1981; Uyttenhove et al. 1983). The characterization of these transplantation antigens has proved very difficult and several different approaches have been followed. One involves the search for specific antibodies to isolate the antigen by immunoprecipitation. Unfortunately, tumors seldom elicit antibodies directed against their specific transplantation antigens. One notable exception is UV-induced tumor 1591, and the molecules that were isolated with these antibodies proved to be modified H-2 class I molecules (Phillips et al. 1985; Linsk et al. 1986). Another approach involves the biochemical fractionation of membrane constituents and the assay of their ability to induce in vivo a specific immune protection against the tumor. It was applied to methylcholanthrene-induced sarcomas and a family of 96-kDa surface glyco-proteins was recently reported to induce a specific immunity (Srivastava et al. 1987). We have used yet another approach aimed at the direct isolation of genes coding for “tum-” transplantation antigens, which are observed on mouse tumor cells treated with mutagens. We begin therefore with a brief description of this system.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Boon T (1983) Antigenic tumor cell variants obtained with mutagen. Adv Cancer Res 39:131–151
Boon T, Kellerman O (1977) Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line. Proc Natl Acad Sci USA 74:272–275
Boon T, Van Snick J, Van Pel A, Uyttenhove C, Marchand M (1980) Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytoly-sis. J Exp Med 152:1184–1193
Contessa A, Bonmassar A, Giampietri A, Circolo A, Goldin A, Fioretti M (1981) In vitro generation of a highly immunogenic subline of L1210 leukemia following exposure to 5-(3,3′-dimethyl-l-triazeno) imidazole-4-carboxamide. Cancer Res 41:2476–2482
De Plaen E, Lurquin C, Van Pel A, Mariamé B, Szikora J-P. Wölfel T, Sibille C, Chomez P, Boon T (1988) Turn− variants of mouse mastocytoma P815.IX. Cloning of the gene of turn− antigen P91A and identification of the turn− mutation. Proc Natl Acad Sci USA 85:2274–2278
Frost P, Kerbel R, Bauer E, Tartamella-Biondo R, Cefalu W (1983) Mutagen treatments as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors. Cancer Res 43:125–132
Hérin M, Lemoine C, Weynants P, Vessière F, Van Pel A, Knuth A, Devos R, Boon T (1987) Production of stable cytolytic T-cell clones directed against autologous human melanoma. Int J Cancer 39:390–396
Klein G, Sjogren HO, Klein E, Hellström KE (1960) Demonstration of resistance against ethylcholanthrene-induced sarcomas in the primary autochthonous host. Cancer Res 20:1561–1572
Kripke MI (1981) Immunologie mechanism in UV radiation carcinogenesis. Adv Cancer Res 34:69–106
Lau Y-F, Kan YW (1983) Versatile cosmid vectors for the isolation, expression and rescue of gene sequences: studies with the human alpha-globin gene cluster. Proc Natl Acad Sci USA 80:5225–5229
Linsk R, Vogel J, Stauss H, Forman J, Goodenow RS (1986) Structure and function of three novel MHC class I antigens derived from a C3H ultraviolet-induced fibrosarcoma. J Exp Med 164:794–813
Maryanski JL, Boon T (1982) Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones. Eur J Immunol 12:406–412
Maryanski JL, Van Snick J, Cerottini J-C, Boon T (1982) Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response. Eur J Immunol 12:401–406
Mukherji B, MacAlister T (1983) Clonal analysis of cytotoxic T cell response against human melanoma. J Exp Med 158:240–245
Philipps C, McMillan M, Flood PM, Murphy DB, Forman J, Lancki D, Womack JE et al (1985) Identification of a unique tumor-specific antigen as a novel class I major histocom-patibility molecule. Proc Natl Acad Sci USA 82:5140–5144
Prehn RT, Main JM (1957) Immunity to methylcholantrene-induced sarcomas. JNCI 18:769–778
Srivastava PK, Chen Y-T, Old LJ (1987) 5′-structural analysis of genes encoding polymorphic antigens of chemically induced tumors. Proc Natl Acad Sci USA 84:3807–3811
Townsend A, Gotch F, Davey J (1985) Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell 42:457–467
Townsend A, Rothbard J, Gotch F, Bahadur G, Wraith D, McMichael A (1986a) The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:959–968
Townsend A, Bastin J, Brownlee G (1986b) Cytotoxic T lymphocytes recognize influenza hemagglutinin that lacks a signal sequence. Nature 324:575–577
Uyttenhove C, Maryanski J, Boon T (1983) Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression. J Exp Med 157:1040–1052
Van Pel A, De Plaen E, Boon T (1985) Selection of a highly transfectable variant from mouse mastocytoma P815. Somatic Cell Genet 11:467–475
Wölfel T, Van Pel A, De Plaen E, Lurquin C, Maryanski JL, Boon T (1987) Immunogenic (turn−) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a turn− antigen with a cytolytic T cell stimulation assay. Immunogenetics 26:178–187
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Boon, T., Van Pel, A., De Plaen, E., Van den Eynde, B., Hainaut, P., Knuth, A. (1989). Identification of Point Mutations in Genes Coding for tum-Antigens. A Step Towards the Understanding of Mouse and Human Tumor-Specific Transplantation Antigens?. In: Schirrmacher, V., Schwartz-Albiez, R. (eds) Cancer Metastasis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74236-1_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-74236-1_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-50471-9
Online ISBN: 978-3-642-74236-1
eBook Packages: Springer Book Archive